Marie-Louise Fjaellskog
Patrimonio netto: - $ in data 31/07/2026
Patrimonio netto: - $ in data 31/07/2026
Marie-Louise Fjaellskog currently works at Faron Pharmaceuticals Oy, as Non-Executive Director from 2023, Biovica International AB, as Director from 2020, Lytix Biopharma AS, as Independent Non-Executive Director from 2021, the University of Uppsala, as Associate Professor from 2008, and Exscientia Ltd., as Chief Medical Officer & Clinical Development Lead from 2024.
Dr. Fjaellskog also formerly worked at Infinity Pharmaceuticals, Inc., as Vice President-Clinical Development from 2018 to 2019, Merus NV, as Vice President-Clinical Development from 2019 to 2020, and Sensei Biotherapeutics, Inc., as Chief Medical Officer from 2020 to 2021.
Dr. Fjaellskog received her doctorate degree from the University of Uppsala.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 31/12/2025 | 0 ( -.--% ) | - $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| FARON PHARMACEUTICALS OY | Direttore/Membro del Consiglio | 22/09/2023 |
| BIOVICA INTERNATIONAL AB | Direttore/Membro del Consiglio | 01/01/2020 |
| LYTIX BIOPHARMA ASA | Direttore/Membro del Consiglio | 01/01/2021 |
| EXSCIENTIA PLC | Direttore Tecnico/Scientifico/R&S | 06/06/2024 |
University of Uppsala
University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/12/2008 |
| Società | Posizione | Fine |
|---|---|---|
| FAETH THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2021 |
| MERUS N.V. | Direttore Tecnico/Scientifico/R&S | 01/06/2020 |
| INFINITY PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 01/04/2019 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 8 |
|---|---|
Infinity Pharmaceuticals, Inc.
Infinity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for the treatment of cancer | Health Technology |
University of Uppsala
University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Faron Pharmaceuticals Oy
Faron Pharmaceuticals Oy Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Merus NV
Merus NV BiotechnologyHealth Technology Discovers and develops therapeutics for cancer treatment | Health Technology |
Lytix Biopharma AS
Lytix Biopharma AS Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company that develops novel cancer immunotherapies | Health Technology |
Biovica International AB
Biovica International AB BiotechnologyHealth Technology Operates as a biotechnology company which develops and commercializes blood-based biomarker assays | Health Technology |
Sensei Biotherapeutics, Inc.
Sensei Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops immunotherapies for cancers and infectious disease | Health Technology |
Exscientia Plc
Exscientia Plc Packaged SoftwareTechnology Services Function as an investment holding company whose subsidiaries provides artificial intelligence and machine learning services | Technology Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale